Scribble

MRK Stock Quote Price and Forecast | CNN

MRK

Merck & Co., Inc.

Key terms

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Nov 22 5:52pm ET Merck (MRK) Recommends that Shareholders Reject TRC Capital’s Mini-Tender Offer by TipRanks Nov 22 4:20pm ET Merck recommends rejection of TRC Capital’s ‘mini-tender’ offer by TipRanks Nov 22 2:49pm ET Merck & Co. Expands Board with New Director by TipRanks Nov 22 12:05pm ET Amazon invests $4B more in Anthropic, Gap reports Q3 beat: Morning Buzz by TipRanks Nov 22 6:51am ET Merck says NMPA in China approves Welireg by TipRanks Nov 22 6:36am ET Merck elects Surendralal Karsanbhai to board of directors by TipRanks Nov 22 6:30am ET U.S. FDA found asthma drug Singular, montelukast impacts the brain, Reuters says by TipRanks Nov 20 4:20pm ET Pyxis Oncology announces preliminary PYX-201 data, collaboration with Merck by TipRanks Nov 20 12:01pm ET Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz by TipRanks Nov 20 9:36am ET Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports by TipRanks Nov 20 8:00am ET Merck target upped at Jefferies after ‘important win’ with subcutaneous Keytruda by TipRanks Nov 19 1:45pm ET Merck ‘linked’ to takeover bid for Incyte, Sky News says by TipRanks Nov 19 12:25pm ET Merck raises quarterly dividend to 81c from 77c per share by TipRanks Nov 19 12:05pm ET Walmart higher, Lowe’s lower after earnings: Morning Buzz by TipRanks Nov 19 6:50am ET Merck announces ‘positive’ results from Phase 3 MK-3475A-D77 trial by TipRanks Nov 15 7:25am ET Merck receives CHMP opinion recommending approval of Keytruda by TipRanks Nov 14 6:45pm ET Wolfe starts Merck at Peer Perform, notes competitive overhangs by TipRanks Nov 14 4:22pm ET Merck initiated with a Peer Perform at Wolfe Research by TipRanks Nov 14 3:05pm ET PDS Biotechnology price target lowered to $4.50 from $7 at Alliance Global Partners by TipRanks Nov 14 6:55am ET Merck enters exclusive global license for LM-299 by TipRanks Nov 13 8:32am ET Zentalis appoints Eastland as CEO, Bruns as CMO, Myers as Chairperson by TipRanks Nov 12 8:20am ET Ginkgo Bioworks receives $9M milestone payment from Merck partnership by TipRanks Nov 12 6:56am ET Merck and AstraZeneca announce results of Koselugo in neurofibromatosis trial by TipRanks Nov 12 6:25am ET AstraZeneca announces Koselugo met primary endpoing in KOMET Phase III trial by TipRanks Nov 11 8:56am ET Citius Pharmaceuticals, Citius Oncology report promising cancer trial results by TipRanks Nov 11 7:28am ET Medicenna announces single-agent activity of MDNA11 from dose expansion cohort by TipRanks Nov 06 8:50am ET Merck price target lowered to $140 from $145 at Deutsche Bank by TipRanks Nov 06 8:45am ET Merck price target lowered to $130 from $137 at Guggenheim by TipRanks Nov 01 8:35am ET Merck price target lowered to $123 from $130 at Morgan Stanley by TipRanks Nov 01 8:17am ET Merck & Company: Overcoming Challenges with Strategic Growth Prospects by TipRanks Nov 01 8:06am ET Merck & Company: Navigating One-Time Charges and Uncertainty in Gardasil Sales Amidst Strategic Shifts by TipRanks

Nov 22 9:00am ET Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know by Zacks Nov 22 3:13am ET The Zacks Analyst Blog Highlights Broadcom, Merck, Qualcomm and Natural Health by Zacks Nov 21 4:49pm ET Top Analyst Reports for Broadcom, Merck & Qualcomm by Zacks Nov 21 3:00pm ET Merck Stock Trades Near 52-Week Low: What's Next for Investors? by Zacks Nov 18 10:32am ET Merck Gets Positive CHMP Opinion for Keytruda in Mesothelioma by Zacks Nov 15 3:00pm ET Pharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline Setback by Zacks Nov 15 2:38pm ET Merck Inks $3.3B Licensing Deal With Chinese Biotech for Cancer Therapy by Zacks Nov 08 9:00am ET Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock by Zacks Nov 07 1:31pm ET Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View by Zacks Nov 05 9:30am ET Stocks and ETFs in Focus as Americans Head to Polls by Zacks Nov 05 8:28am ET Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings? by Zacks Nov 01 3:00pm ET Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus by Zacks Oct 31 11:42am ET Merck Q3 Earnings & Sales Top, Stock Down on Lowered '24 View by Zacks Oct 31 9:30am ET Merck (MRK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates by Zacks Oct 31 8:42am ET Summit Therapeutics Posts Wider-Than-Expected Loss in Q3, Nil Sales by Zacks Oct 31 7:40am ET Merck (MRK) Q3 Earnings and Revenues Top Estimates by Zacks Oct 30 10:07am ET Exelixis Beats on Q3 Earnings and Sales, Raises Annual Outlook by Zacks Oct 30 7:55am ET Eli Lilly (LLY) Lags Q3 Earnings and Revenue Estimates by Zacks Oct 28 12:06pm ET Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts? by Zacks Oct 28 9:16am ET Exploring Analyst Estimates for Merck (MRK) Q3 Earnings, Beyond Revenue and EPS by Zacks Oct 25 12:42pm ET Merck to Report Q3 Earnings: To Buy or Not to Buy MRK Stock? by Zacks Oct 24 11:49am ET Biotech Stock Roundup: FOLD Settles Patent Dispute, Updates From EDIT & More by Zacks Oct 24 10:01am ET Analysts Estimate Merck (MRK) to Report a Decline in Earnings: What to Look Out for by Zacks Oct 24 9:28am ET Summit Therapeutics Stock: Sell or Hold Before Q3 Earnings? by Zacks Oct 24 9:00am ET Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know by Zacks Oct 23 9:41am ET Summit Stock Skyrockets Nearly 700% YTD: Time to Sell or Hold? by Zacks Oct 22 5:50pm ET Merck (MRK) Advances While Market Declines: Some Information for Investors by Zacks Oct 22 5:30am ET The Zacks Analyst Blog Highlights Visa, Netflix, Merck and Hovnanian by Zacks Oct 21 4:52pm ET Top Research Reports for Visa, Netflix & Merck by Zacks Oct 21 3:00pm ET Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold? by Zacks Oct 21 1:50pm ET Gilead, MRK Report Data From Investigational Combination Study for HIV by Zacks

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.

David Paul Morris/Bloomberg/Getty Images

Target sounds the alarm bell on holiday shopping

Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.

Angela Weiss/AFP/Getty Images

Stocks shrug off concerns about heightened US-Russia tensions

A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.

David Zalubowski/AP

As Americans bargain shop, six-figure earners flock to Walmart

NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)

Leonardo Munoz/VIEWpress/Getty Images

Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion